West Pharmaceutical Services | WST - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Align Technology USD 4.15B 100.27M 2026-03
Avanos Medical USD 782.1M 3.9M 2026-03
Baxter International USD 6.04B 86M 2026-03
Becton, Dickinson and Co. USD 24.13B 1.15B 2026-03
Cerus USD 64.22M 2.76M 2025-12
Charles River Laboratories USD 2.9B 265.94M 2026-03
Cooper Companies USD 8.36B 124.7M 2025-12
Dentsply International USD 1.32B 21M 2026-03
Haemonetics USD 796.32M 115.13M 2026-03
ICU Medical USD 2.11B 11.9M 2026-03
Insulet USD 1.3B 212.6M 2026-03
Integra LifeSciences USD 1.04B 1.06M 2026-03
IQVIA Holdings USD 6.22B 282M 2026-03
J&J USD 81.19B 358M 2026-03
Medtronic USD 48.99B 128M 2025-12
Merit Medical Systems USD 1.63B 42.42M 2026-03
Neogen USD 2.1B 2.09M 2025-12
OraSure Technologies USD 313.32M 27.5M 2026-03
Quidel USD 1.85B 69.1M 2026-03
Repligen USD 2.11B 666K 2026-03
Rockwell Medical USD 30.41M 1.11M 2025-06
Solventum Corp USD 4.97B 80M 2026-03
STAAR Surgical USD 352.37M 8.18M 2026-03
Terumo JPY 1.58T 62.18B 2026-03
Utah Medical Products USD 119.27M 1.02M 2025-12
West Pharmaceutical Services USD 2.99B 185.6M 2026-03